Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
444 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00938652 | A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer | completed | Phase 3 | 519 | SanofiINDUSTRY | 1 | Sep 19, 2013 | clinicaltrials |
| NCT01130259 | An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer | no longer available | — | — | SanofiINDUSTRY | 0 | Sep 17, 2013 | clinicaltrials |
| NCT01001221 | Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor | terminated | Phase 1 / Phase 2 | 19 | SanofiINDUSTRY | 1 | Sep 11, 2013 | clinicaltrials |
| NCT00017459 | Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 3 | — | SanofiINDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01907685 | Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors | completed | Phase 1 | 58 | SanofiINDUSTRY | 0 | Jul 25, 2013 | clinicaltrials |
| NCT01087658 | Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity(GLUTOX) | completed | Phase 3 | 200 | SanofiINDUSTRY | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00485719 | Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors | completed | Phase 1 | 83 | SanofiINDUSTRY | 2 | May 30, 2013 | clinicaltrials |
| NCT01213381 | Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | SanofiINDUSTRY | 1 | May 24, 2013 | clinicaltrials |
| NCT00925743 | A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer | completed | Phase 1 | 76 | SanofiINDUSTRY | 1 | May 16, 2013 | clinicaltrials |
| NCT00704080 | A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas | completed | Phase 1 | 54 | SanofiINDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00756847 | Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors | completed | Phase 1 | 52 | SanofiINDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01439919 | A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain(ACT11705) | terminated | Phase 2 | 5 | SanofiINDUSTRY | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00719524 | AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor | completed | Phase 1 | 71 | SanofiINDUSTRY | 3 | Mar 11, 2013 | clinicaltrials |
| NCT00411229 | Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer(CLASSIC) | completed | Phase 3 | 1,035 | SanofiINDUSTRY | 3 | Feb 20, 2013 | clinicaltrials |
| NCT00464633 | Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 165 | SanofiINDUSTRY | 9 | Feb 12, 2013 | clinicaltrials |
| NCT00486135 | Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma | completed | Phase 1 | 118 | SanofiINDUSTRY | 2 | Feb 1, 2013 | clinicaltrials |
| NCT01097369 | Elitek (Rasburicase) Immuno-Monitoring Study | terminated | — | 1 | SanofiINDUSTRY | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00694382 | Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy(SAVE-ONCO) | completed | Phase 3 | 3,212 | SanofiINDUSTRY | 49 | Jan 23, 2013 | clinicaltrials |
| NCT00396591 | AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites | completed | Phase 2 | 16 | SanofiINDUSTRY | 3 | Jan 10, 2013 | clinicaltrials |
| NCT00382720 | Docetaxel and Oxaliplatin in Gastric Cancer | completed | Phase 2 | 275 | SanofiINDUSTRY | 12 | Jan 7, 2013 | clinicaltrials |
| NCT00327444 | Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | completed | Phase 2 / Phase 3 | 58 | SanofiINDUSTRY | 9 | Jan 1, 2013 | clinicaltrials |
| NCT00540358 | A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer | completed | Phase 2 | 123 | SanofiINDUSTRY | 1 | Dec 28, 2012 | clinicaltrials |
| NCT01755390 | A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | SanofiINDUSTRY | 2 | Dec 24, 2012 | clinicaltrials |
| NCT00816543 | Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Dec 18, 2012 | clinicaltrials |
| NCT00284141 | Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma | completed | Phase 2 | 98 | SanofiINDUSTRY | 3 | Dec 10, 2012 | clinicaltrials |
| NCT00921661 | Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 16 | SanofiINDUSTRY | 1 | Nov 9, 2012 | clinicaltrials |
| NCT01107756 | A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen(Grano-Tax) | completed | Phase 4 | 403 | SanofiINDUSTRY | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00561470 | Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen(VELOUR) | completed | Phase 3 | 1,226 | SanofiINDUSTRY | 28 | Sep 28, 2012 | clinicaltrials |
| NCT00917748 | Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF) | completed | Phase 3 | 84 | SanofiINDUSTRY | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00811447 | Taxotere New Indication - Gastric Cancer Treatment Registration Trial | completed | Phase 3 | 243 | SanofiINDUSTRY | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00296816 | TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary(TEACO) | completed | Phase 2 | 132 | SanofiINDUSTRY | 1 | Aug 23, 2012 | clinicaltrials |
| NCT00364611 | Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer | completed | Phase 2 | 73 | SanofiINDUSTRY | 1 | Aug 23, 2012 | clinicaltrials |
| NCT00452985 | Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer(OCSTUD) | completed | — | 30 | SanofiINDUSTRY | 1 | Aug 14, 2012 | clinicaltrials |
| NCT00298675 | Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors | completed | Phase 1 | 59 | SanofiINDUSTRY | 1 | Aug 2, 2012 | clinicaltrials |
| NCT01240460 | Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection | completed | Phase 1 | 40 | SanofiINDUSTRY | 1 | Jul 27, 2012 | clinicaltrials |
| NCT00796731 | SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma | completed | Phase 1 | 77 | SanofiINDUSTRY | 1 | Jul 17, 2012 | clinicaltrials |
| NCT00436839 | Taxotere Prostate Cancer New Indication Registration Trial in China | completed | Phase 3 | 228 | SanofiINDUSTRY | 1 | Jul 9, 2012 | clinicaltrials |
| NCT00261703 | Docetaxel in Head and Neck Cancer | completed | Phase 2 / Phase 3 | 439 | SanofiINDUSTRY | 2 | May 11, 2012 | clinicaltrials |
| NCT00981240 | Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes | completed | Phase 1 | 30 | SanofiINDUSTRY | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00692640 | Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors | completed | Phase 1 | 35 | SanofiINDUSTRY | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00664144 | Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma(GRAAL2) | terminated | Phase 2 | 33 | SanofiINDUSTRY | 4 | Mar 7, 2012 | clinicaltrials |
| NCT00174564 | EXIBIT: Oxaliplatin in Biliary Tract Cancer | completed | Phase 2 | 67 | SanofiINDUSTRY | 0 | Feb 17, 2012 | clinicaltrials |
| NCT00549185 | Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma | completed | Phase 1 | 39 | SanofiINDUSTRY | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00777699 | Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors | completed | Phase 1 | 80 | SanofiINDUSTRY | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00283062 | Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy | completed | Phase 3 | 228 | SanofiINDUSTRY | 17 | Jan 26, 2012 | clinicaltrials |
| NCT01008774 | START: Swiss Taxotere Alopecia Prevention Trial | completed | N/A | 239 | SanofiINDUSTRY | 1 | Jan 23, 2012 | clinicaltrials |
| NCT01148615 | A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors | completed | Phase 1 | 20 | SanofiINDUSTRY | 1 | Jan 13, 2012 | clinicaltrials |
| NCT01063946 | A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor | completed | Phase 1 | 3 | SanofiINDUSTRY | 1 | Dec 21, 2011 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials